Why the study?
Does intravenous verapamil cause cardiovascular collapse in neonates with supraventricular tachycardia?
Does intravenous verapamil cause cardiovascular collapse in neonates with supraventricular tachycardia?
Intravenous verapamil should not be used in the initial management of supraventricular tachycardia in neonates due to the risk of severe hypotension and death.
Answers are grounded in this paper and cite their sources.
IV verapamil associated with severe hypotension in neonates; leaves open safer first-line SVT therapies for prospective evaluation.
Five babies who presented with supraventricular tachycardia were treated with verapamil intravenously. All developed severe hypotension and two died. Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.
No takes yet. Share an insight, caveat, or question.
Kirk et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: